Rave minimizes trial costs and drive studies in any clinical research environment, across global sites and in multiple languages, claims Medidata.

Rave will also enable CCRC’s team to further increase collaboration with both Japanese and international university hospitals throughout Asia, the US and Europe.

Chiba University Hospital Clinical Research Center assistant professor Yasuhisa Fujii said they look forward to benefit from Medidata Rave’s configurable and user-friendly EDC/CDM system.

Medidata Solutions CEO Tarek Sherif said Medidata’s Rave will support the CCRC in its ability to increase the number of trials it takes on each year, while also building and strengthening relationships with both pharmaceutical and academic research organizations.